Nesta página
LFWD Lifeward Ltd. - Ordinary Shares
NASDAQ · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 14, 2026
$5,85
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$4,14mínima 52 sem
$10,20máxima 52 sem
Capitalização de Mercado (MRQ)
$17M
P/E (TTM)
-0.2
EPS (TTM)
$-26.94
Receita (TTM)
$22M
seus distintivos
Intervalo 52 Semanas
$4–$10
Classificação do Analista
BUY
Preço-Alvo
$20
P/E
-0.2
ROE
-225.6%
Margem de Lucro Líquido
-141.3%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
LFWD Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$5.85
Capitalização de Mercado (MRQ)
$17M
P/E (TTM)
-0.2
EPS (TTM)
$-26.94
Receita (TTM)
$22M
ROE (TTM)
-225.6%
Intervalo 52 Semanas
$4–$10
LFWD Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 24 de Fevereiro de 2026 | 1-for-12 | Reverso |
| 15 de Março de 2024 | 1-for-7 | Reverso |
| 1 de Abril de 2019 | 1-for-25 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$22M2016-12-31 → 2025-12-31
EPS$-17.162020-12-31 → 2025-12-31
Fluxo de caixa livre$-17M2017-12-31 → 2025-12-31
Margem líquida-141.3%2017-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | LFWD | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | -0.2média 5A ≈-6.9 | ≈-6.9 | · | · | |
| P/S (TTM) | 0.8 | · | · | · | |
| P/B (MRQ) | 1.4 | · | · | · | |
| Preço / FCF (TTM) | -1.0 | · | · | · | |
| Preço / Fluxo de Caixa (TTM) | -1.0 | · | · | · | |
| Price / Tangible Book (Preço / Valor Patrimonial Tangível) | 2.4média 5A ≈4.9 | ≈4.9 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | LFWD | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 36.0% | · | · | · | |
| Margem Operacional (TTM) | -104.2% | · | · | · | |
| EBITDA Margin (Margem EBITDA) | -89.3% | · | · | · | |
| Margem de Impostos Pré-Tributação (TTM) | -141.5% | · | · | · | |
| Margem de Lucro Líquido (TTM) | -141.3% | · | · | · | |
| ROA (TTM) | -99.8% | · | · | · | |
| ROE (TTM) | -225.6% | · | · | · | |
| ROIC | -233.3% | · | · | · |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | LFWD | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 2.3 | · | · | · | |
| Quick Ratio (Índice de Liquidez Seca) | 0.7 | · | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | LFWD | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -14.1%média 5A ≈50.1% | ≈50.1% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 58.7%média 5A ≈56.0% | ≈56.0% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 38.1% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | LFWD | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.8 | · | · | · | |
| Inventory Turnover (Giro de Estoque) | 2.2 | · | · | · | |
| Receivables Turnover (Giro de Contas a Receber) | 3.6 | · | · | · | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$272.0K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-110.2%
Próximo relatório
Nov 12, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 14, 2026 | $-1.46 | $-1.37 | -6.8% |
| 31 de Março de 2026 | Mai 15, 2026 | $-6.70 | $-1.28 | -423.4% |
| 31 de Dezembro de 2025 | $-3.60 | $-1.10 | -226.8% | |
| 30 de Setembro de 2025 | $-2.40 | $-2.63 | 8.8% | |
| 30 de Junho de 2025 | $-6.96 | $-3.73 | -86.4% | |
| 31 de Março de 2025 | $-5.52 | $-4.65 | -18.7% | |
| 31 de Dezembro de 2024 | $-7.44 | $-6.28 | -18.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22M | $26M | $14M | $6M | $6M | $4M | $5M | $7M | $8M | $6M | $4M | $4M | |
| Cost of Revenue | $14M | $17M | $9M | $4M | $3M | $2M | $2M | $4M | $5M | $5M | $4M | $4M | |
| Gross Profit | $8M | $8M | $4M | $2M | $3M | $2M | $3M | $3M | $3M | $736.0K | $214.0K | $-621.0K | |
| R&D Expense | $3M | $5M | $4M | $4M | $3M | $3M | $5M | $7M | $6M | $9M | $6M | $9M | |
| SG&A Expense | $8M | $5M | $10M | $7M | $6M | $5M | $5M | $7M | $8M | $8M | $6M | $3M | |
| Operating Expenses | $28M | $38M | $28M | $21M | $16M | $14M | $17M | $22M | $25M | $31M | $25M | $19M | |
| Operating Income | $-20M | $-29M | $-24M | $-19M | $-13M | $-12M | $-14M | $-19M | $-22M | $-30M | $-25M | $-20M | |
| Pretax Income | $-20M | $-29M | $-22M | $-19M | $-13M | $-13M | $-16M | $-22M | $-25M | $-32M | $-25M | $-22M | |
| Income Tax | $-55.0K | $43.0K | $-12.0K | $467.0K | $94.0K | $51.0K | $7.0K | $-5.0K | $119.0K | $3.0K | $53.0K | $45.0K | |
| Net Income | $-20M | $-29M | $-22M | $-20M | $-13M | $-13M | $-16M | $-22M | $-25M | $-33M | $-25M | $-22M | |
| EPS (Basic) | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 | $-0.82 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 | $-0.82 | · | · | · | · | · | · | |
| Shares (Basic) | 1,160,521 | 724,272 | 710,941 | 8,911,256 | 47,935,652 | 15,764,980 | · | · | · | · | · | · | |
| Shares (Diluted) | 1,160,521 | 724,272 | 710,941 | 8,911,256 | 47,935,652 | 15,764,980 | · | · | · | · | · | · | |
| EBITDA | $-20M | $-29M | · | · | · | $-12M | · | $-19M | $-21M | · | · | $-20M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $7M | $28M | $68M | $88M | $20M | $16M | $10M | $15M | $24M | $18M | $42M | |
| Receivables | $6M | $6M | $3M | $1M | $585.0K | $684.0K | $794.0K | $758.0K | $1M | $1M | $2M | $2M | |
| Inventory | $6M | $7M | $6M | $3M | $3M | $4M | $3M | $2M | $4M | $3M | $3M | $777.0K | |
| Prepaid Expense | $2M | $2M | $2M | $649.0K | $610.0K | $672.0K | $903.0K | $693.0K | $2M | $1M | $1M | $756.0K | |
| Other Current Assets | $393.0K | $289.0K | $747.0K | $152.0K | $63.0K | $33.0K | $164.0K | · | $458.0K | $671.0K | $512.0K | $89.0K | |
| Current Assets | $16M | $21M | $39M | $73M | $93M | $25M | $21M | $13M | $21M | $29M | $24M | $47M | |
| PP&E (Net) | $585.0K | $867.0K | $1M | $196.0K | $284.0K | $437.0K | $501.0K | $626.0K | $840.0K | $1M | $1M | $414.0K | |
| PP&E (Gross) | $8M | $8M | $8M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $749.0K | |
| Accum. Depreciation | $7M | $7M | $6M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $773.0K | $335.0K | |
| Goodwill | $5M | $8M | $8M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | · | $0 | $13M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $209.0K | $240.0K | $784.0K | $694.0K | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Total Assets | $23M | $30M | $63M | $74M | $95M | $28M | $24M | $15M | $23M | $32M | $26M | $48M | |
| Accounts Payable | $6M | $5M | $5M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $2M | $1M | |
| Current Liabilities | $12M | $10M | $12M | $5M | $4M | $5M | $10M | $5M | $10M | $12M | $4M | $4M | |
| Capital Leases | $1M | $22.0K | $607.0K | $333.0K | $418.0K | $923.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $61.0K | $67.0K | $58.0K | $66.0K | $45.0K | $35.0K | $61.0K | $239.0K | $256.0K | $303.0K | $140.0K | $66.0K | |
| Total Liabilities | $14M | $12M | $17M | $6M | $5M | $6M | $14M | $13M | $19M | $24M | $5M | $4M | |
| Long-term Debt | · | · | · | · | · | · | $7M | $9M | $15M | $18M | $0 | · | |
| Total Debt | · | · | · | · | · | · | · | $9M | $15M | · | · | · | |
| Common Stock | $9M | $5M | $4M | $4M | $5M | $2M | $504.0K | $193.0K | $84.0K | $45.0K | $33.0K | $32.0K | |
| Paid-in Capital | $287M | $282M | $281M | $280M | $279M | $201M | $179M | $155M | $135M | $115M | $95M | $92M | |
| Retained Earnings | $-285M | $-265M | $-236M | $-214M | $-194M | $-181M | $-168M | $-153M | $-131M | $-106M | $-74M | $-49M | |
| Treasury Stock | $3M | $3M | $3M | $2M | $0 | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $19M | $47M | $68M | $89M | $22M | $11M | $2M | $4M | $8M | $21M | $44M | |
| Liabilities + Equity | $23M | $30M | $63M | $74M | $95M | $28M | $24M | $15M | $23M | $32M | $26M | $48M | |
| Shares Outstanding | 1,524,431 | 733,966 | 8,587,140 | 60,090,298 | 62,480,163 | 25,332,225 | 7,319,560 | 2,813,087 | 30,003,639 | 16,338,257 | 12,222,583 | 11,978,554 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $642.0K | $696.0K | $438.0K | $111.0K | |
| Stock-based Comp | $743.0K | $1M | $1M | $993.0K | $833.0K | $749.0K | $1M | $3M | $4M | $3M | $2M | $5M | |
| Deferred Tax | · | $0 | $0 | $316.0K | $-29.0K | $-44.0K | $-57.0K | $-107.0K | $73.0K | $-5.0K | $-61.0K | $-60.0K | |
| Amort. of Intangibles | $0 | $3M | $2M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | $-2M | · | · | $1M | |
| Operating Cash Flow | $-17M | $-22M | $-21M | $-18M | $-11M | $-13M | $-15M | $-15M | $-22M | $-27M | $-25M | $-15M | |
| CapEx | $16.0K | $0 | $81.0K | $25.0K | $47.0K | $73.0K | $22.0K | $13.0K | $21.0K | $452.0K | $584.0K | $169.0K | |
| Investing Cash Flow | $-16.0K | $0 | $-18M | $-25.0K | $-47.0K | $-73.0K | $-22.0K | $-13.0K | $-21.0K | $-437.0K | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $392.0K | · | · | · | $20M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | $-7M | · | $-4M | $-3M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $1M | $9M | $4M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $1M | $9M | · | · | $36M | |
| Financing Cash Flow | $12M | $0 | $-992.0K | $-2M | $80M | $17M | $21M | $10M | $13M | $34M | · | · | |
| Net Change in Cash | $-5M | $-22M | $-40M | $-20M | $68M | $4M | · | · | $-9M | $6M | $-24M | $33M | |
| Taxes Paid | $36.0K | $-7.0K | $126.0K | $113.0K | · | · | · | $2M | $2M | $1M | $163.0K | $0 | |
| Free Cash Flow | $-17M | $-22M | · | · | · | $-13M | · | $-15M | $-23M | · | · | $-15M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.2% | 32.0% | · | · | · | 49.8% | · | 43.2% | 40.0% | · | · | -15.7% | |
| Operating Margin | -89.3% | -114.4% | · | · | · | -273.2% | · | -293.6% | -283.7% | · | · | -504.3% | |
| Net Margin | -90.4% | -112.8% | · | · | · | -295.4% | · | -331.2% | -318.8% | · | · | -548.4% | |
| Pretax Margin | -90.6% | -112.6% | · | · | · | -294.2% | · | -331.2% | -317.3% | · | · | -547.3% | |
| EBITDA Margin | -89.3% | -114.4% | · | · | · | -273.2% | · | -293.6% | -275.4% | · | · | -501.5% | |
| ROA | -74.6% | -61.8% | · | · | · | -49.5% | · | -114.6% | -90.5% | · | · | -73.8% | |
| ROE | -169.3% | -109.7% | · | · | · | -67.3% | · | 1323.3% | -413.1% | · | · | -87.6% | |
| ROIC | -233.3% | -155.9% | · | · | · | -55.4% | · | -180.7% | -116.0% | · | · | -45.5% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.1 | · | · | · | 5.4 | · | 2.5 | 2.2 | · | · | 13.1 | |
| Quick Ratio | 0.7 | 1.2 | · | · | · | 4.5 | · | 1.9 | 1.6 | · | · | 12.3 | |
| Debt / Equity | · | · | · | · | · | · | · | 4.5 | 4.1 | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 3.6 | 2.4 | · | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.5 | · | · | · | 0.2 | · | 0.3 | 0.3 | · | · | 0.1 | |
| Inventory Turnover | 2.2 | 2.8 | · | · | · | 0.7 | · | 1.3 | 1.3 | · | · | 4.7 | |
| Receivables Turnover | 3.6 | 5.6 | · | · | · | 5.9 | · | 7.0 | 6.6 | · | · | 3.5 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.52 | $2.14 | · | · | · | $0.86 | · | $0.03 | $0.12 | · | · | $3.66 | |
| Revenue / Share | $18.99 | $2.95 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-14.50 | $-2.50 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.42 | $0.77 | · | · | · | $0.80 | · | $0.14 | $0.49 | · | · | $3.49 | |
| EPS (TTM) | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 | $-0.82 | · | · | · | · | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.1% | 85.2% | 151.4% | -7.6% | 35.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 58.7% | 62.6% | 46.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 38.1% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $26M | $14M | $6M | $6M | $4M | $5M | $7M | $8M | $6M | $4M | $4M | |
| Net Income TTM | $-20M | $-29M | $-22M | $-20M | $-13M | $-13M | $-16M | $-22M | $-25M | $-33M | $-25M | $-22M | |
| Market Cap | $879.6K | $15M | · | · | · | $234M | · | $2.14B | $5.78B | · | · | $474.93B | |
| Enterprise Value | · | · | · | · | · | · | · | $2.14B | $5.78B | · | · | · | |
| P/E | -0.0 | -0.0 | -0.2 | -2.4 | -31.9 | -11.3 | · | · | · | · | · | · | |
| P/S | 0.0 | 0.6 | · | · | · | 53.3 | · | 327.2 | 745.0 | · | · | 120203.9 | |
| P/B | 0.1 | 0.8 | · | · | · | 10.8 | · | 1101.0 | 1558.1 | · | · | 10829.9 | |
| P / Tangible Book | 0.2 | 1.3 | 12.4 | 4.7 | 6.0 | 10.8 | · | · | · | · | · | · | |
| P / Cash Flow | -0.1 | -0.7 | · | · | · | -18.6 | · | -144.9 | -256.7 | · | · | -31002.4 | |
| P / FCF | -0.1 | -0.7 | · | · | · | -18.5 | · | -144.8 | -256.5 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | -111.4 | -270.6 | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | -144.8 | -256.5 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 327.1 | 745.1 | · | · | · | |
| Earnings Yield | -2974.0% | -2309.8% | -571.6% | -41.3% | -3.1% | -8.9% | · | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $4M | $5M | $6M | $6M | $5M | $8M | $6M | $7M | $5M | $7M | $4M | $1M | $1M | $2M | $886.0K | |
| Cost of Revenue | $4M | $3M | $4M | $3M | $3M | $3M | $6M | $4M | $4M | $4M | $4M | $4M | $761.0K | $659.0K | $2M | $665.0K | |
| Gross Profit | $3M | $1M | $1M | $3M | $3M | $2M | $2M | $2M | $3M | $1M | $2M | $863.0K | $576.0K | $571.0K | $673.0K | $221.0K | |
| R&D Expense | $2M | $6M | $843.0K | $721.0K | $767.0K | $918.0K | $1M | $998.0K | $1M | $1M | $1M | $1M | $816.0K | $752.0K | $1M | $1M | |
| SG&A Expense | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $240.0K | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $7M | $12M | $6M | $6M | $9M | $7M | $17M | $5M | $7M | $8M | $9M | $9M | $6M | $5M | $6M | $6M | |
| Operating Income | $-4M | $-10M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-7M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| Interest Expense | $7M | $416.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $394.0K | $557.0K | $73.0K | · | $0 | |
| Pretax Income | $-12M | $-11M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| Income Tax | $10.0K | $6.0K | $-73.0K | $7.0K | $0 | $11.0K | $3.0K | $29.0K | $5.0K | $6.0K | $-78.0K | $0 | $42.0K | $24.0K | $377.0K | $26.0K | |
| Net Income | $-12M | $-11M | $-5M | $-3M | $-7M | $-5M | $-15M | $-3M | $-4M | $-6M | $-6M | $-8M | $-5M | $-4M | $-5M | $-5M | |
| EPS (Basic) | $-4.12 | $-6.70 | $-15.92 | $-0.20 | $-7.01 | $-5.53 | $-38.38 | $-0.35 | $-0.50 | $-0.73 | $-29.19 | $-0.88 | $-0.55 | $-0.51 | $-1.97 | $-0.09 | |
| EPS (Diluted) | $-4.12 | $-6.70 | $-15.92 | $-0.20 | $-7.01 | $-5.53 | $-38.38 | $-0.35 | $-0.50 | $-0.73 | $-29.19 | $-0.88 | $-0.55 | $-0.51 | $-1.97 | $-0.09 | |
| Shares (Basic) | 2,796,621 | 1,610,969 | · | 16,021,411 | 935,785 | 873,845 | · | 8,756,882 | 8,608,937 | 8,590,088 | · | 8,542,630 | 8,502,201 | 8,502,217 | · | 62,793,847 | |
| Shares (Diluted) | 2,796,621 | 1,610,969 | · | 16,021,411 | 935,785 | 873,845 | · | 8,756,882 | 8,608,937 | 8,590,088 | · | 8,542,630 | 8,502,201 | 8,502,217 | · | 62,793,847 | |
| EBITDA | $-4M | $-10M | · | $-3M | $-7M | $-5M | · | $-3M | $-4M | $-7M | · | $-8M | $-5M | $-4M | · | $-5M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $11M | $2M | $2M | $5M | $6M | $7M | $11M | $15M | $21M | · | $33M | $58M | $62M | · | $74M | |
| Receivables | $8M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $5M | $3M | · | $4M | $774.0K | $532.0K | · | $447.0K | |
| Inventory | $6M | $6M | $6M | $7M | $8M | $7M | $7M | $7M | $7M | $6M | · | $6M | $3M | $3M | · | $3M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $1M | |
| Other Current Assets | · | · | $393.0K | · | · | · | $289.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $26M | $26M | $16M | $17M | $21M | $20M | $21M | $26M | $30M | $33M | · | $44M | $64M | $67M | · | $79M | |
| PP&E (Net) | $527.0K | $571.0K | $585.0K | $641.0K | $730.0K | $777.0K | $867.0K | $1M | $1M | $1M | · | $1M | $129.0K | $160.0K | · | $237.0K | |
| PP&E (Gross) | · | · | $8M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $5M | $5M | $5M | $5M | $8M | $8M | $8M | $8M | $8M | · | $8M | · | · | · | · | |
| Intangibles | · | · | · | · | · | $0 | · | $10M | $11M | $12M | · | $13M | · | · | · | · | |
| Other Non-current Assets | $488.0K | $436.0K | $209.0K | $205.0K | $228.0K | $219.0K | $240.0K | $436.0K | $430.0K | $432.0K | · | $772.0K | $689.0K | $692.0K | · | $1M | |
| Total Assets | $35M | $33M | $23M | $23M | $27M | $29M | $30M | $46M | $51M | $55M | · | $69M | $66M | $69M | · | $81M | |
| Accounts Payable | $6M | $6M | $6M | $5M | $6M | $4M | $5M | $5M | $5M | $4M | · | $6M | $3M | $2M | · | $2M | |
| Current Liabilities | $11M | $11M | $12M | $9M | $10M | $9M | $10M | $10M | $10M | $10M | · | $13M | $5M | $4M | · | $4M | |
| Capital Leases | $2M | $1M | $1M | $88.0K | $79.0K | $48.0K | $22.0K | $45.0K | $123.0K | $354.0K | · | $856.0K | $541.0K | $657.0K | · | $85.0K | |
| Other Non-current Liabilities | $54.0K | $54.0K | $61.0K | $63.0K | $51.0K | $61.0K | $67.0K | $82.0K | $89.0K | $84.0K | · | $387.0K | $13.0K | $24.0K | · | $68.0K | |
| Total Liabilities | $23M | $27M | $14M | $10M | $12M | $10M | $12M | $12M | $14M | $15M | · | $17M | $7M | $5M | · | $5M | |
| Common Stock | $0 | $9M | $9M | $9M | $8M | $5M | $5M | $5M | $5M | $4M | · | $4M | $4M | $4M | · | $5M | |
| Paid-in Capital | $322M | $296M | $287M | $287M | $287M | $286M | $282M | $282M | $282M | $281M | · | $281M | $280M | $280M | · | $280M | |
| Retained Earnings | $-307M | $-296M | $-285M | $-279M | $-276M | $-270M | $-265M | $-250M | $-246M | $-242M | · | $-230M | $-223M | $-218M | · | $-208M | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $170.0K | |
| Stockholders' Equity | $12M | $6M | $8M | $13M | $15M | $18M | $19M | $34M | $37M | $41M | $47M | $52M | $59M | $64M | $68M | $76M | |
| Liabilities + Equity | $35M | $33M | $23M | $23M | $27M | $29M | $30M | $46M | $51M | $55M | · | $69M | $66M | $69M | · | $81M | |
| Shares Outstanding | 2,828,362 | 2,778,585 | 1,524,431 | 16,862,859 | 15,658,730 | 10,630,281 | 733,966 | 8,805,633 | 8,630,902 | 8,601,844 | · | 60,024,517 | 59,346,139 | 59,482,004 | · | 62,717,316 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $262.0K | $177.0K | $167.0K | $174.0K | $182.0K | $220.0K | $234.0K | $290.0K | $376.0K | $381.0K | $373.0K | $333.0K | $318.0K | $304.0K | $347.0K | $320.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $314.0K | $9.0K | |
| Amort. of Intangibles | $-5M | $5M | $0 | $0 | $0 | $0 | $842.0K | $842.0K | $832.0K | $831.0K | $844.0K | $764.0K | $0 | $0 | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | $-6M | $-8M | $-4M | $-7M | $-4M | $-5M | $-4M | $-5M | |
| CapEx | $8.0K | $0 | $11.0K | $0 | $0 | $5.0K | $0 | $0 | $0 | $0 | $79.0K | $2.0K | $0 | $0 | $0 | $7.0K | |
| Investing Cash Flow | $-28.0K | $6M | $-11.0K | $0 | $0 | $-5.0K | $0 | $0 | $0 | $0 | $-79.0K | $-18M | $0 | $0 | $0 | $-7.0K | |
| Financing Cash Flow | $4M | $6M | $4M | $646.0K | $3M | $4M | $0 | $0 | $0 | $0 | $0 | $-6.0K | $-215.0K | $-771.0K | $-2M | $-183.0K | |
| Net Change in Cash | $-2M | $9M | $219.0K | $-3M | $-565.0K | $-1M | $-4M | $-4M | $-6M | $-8M | $-4M | $-26M | $-4M | $-6M | $-6M | $-5M | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-8M | · | · | · | $-5M | · | · | |
| Levered FCF | · | $-4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.9% | 34.2% | · | 43.7% | 43.9% | 42.1% | · | 36.2% | 41.1% | 26.4% | · | 19.6% | 43.1% | 46.4% | · | 24.9% | |
| Operating Margin | -62.7% | -263.6% | · | -50.7% | -114.7% | -96.4% | · | -51.8% | -66.2% | -123.1% | · | -180.4% | -385.8% | -355.7% | · | -613.2% | |
| Net Margin | -173.9% | -275.1% | · | -51.2% | -114.6% | -96.0% | · | -50.3% | -64.2% | -118.8% | · | -171.0% | -347.2% | -351.3% | · | -616.2% | |
| Pretax Margin | -173.8% | -275.0% | · | -51.1% | -114.6% | -95.8% | · | -49.9% | -64.1% | -118.7% | · | -171.0% | -344.1% | -349.4% | · | -613.3% | |
| EBITDA Margin | -62.7% | -263.6% | · | -50.7% | -114.7% | -96.4% | · | -51.8% | -66.2% | -123.1% | · | -180.4% | -385.8% | -355.7% | · | -613.2% | |
| ROA | -37.3% | -34.7% | · | -9.2% | -16.9% | -11.5% | · | -5.4% | -7.4% | -10.1% | · | -10.0% | -6.1% | -5.4% | · | -6.1% | |
| ROE | -84.3% | -87.2% | · | -13.6% | -25.3% | -16.4% | · | -7.2% | -9.0% | -12.0% | · | -11.8% | -6.6% | -5.8% | · | -6.5% | |
| ROIC | -34.0% | -164.4% | · | -24.7% | -43.4% | -26.4% | · | -9.4% | -12.1% | -16.0% | · | -15.3% | -8.8% | -6.9% | · | -7.2% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | · | 1.9 | 2.0 | 2.2 | · | 2.7 | 3.0 | 3.2 | · | 3.5 | 11.7 | 17.2 | · | 18.7 | |
| Quick Ratio | 1.6 | 1.6 | · | 0.9 | 1.1 | 1.2 | · | 1.7 | 2.0 | 2.4 | · | 2.8 | 10.8 | 16.1 | · | 17.6 | |
| Interest Coverage | -0.6 | -24.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.6 | 0.4 | · | 0.5 | 0.4 | 0.5 | · | 0.6 | 0.8 | 0.9 | · | 0.8 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.0 | 0.7 | · | 1.0 | 1.0 | 1.2 | · | 1.3 | 2.2 | 2.6 | · | 2.2 | 1.6 | 2.2 | · | 1.0 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.32 | $2.26 | · | $0.76 | $0.96 | $1.74 | · | $3.85 | $4.25 | $4.72 | · | $0.86 | $0.99 | $1.07 | · | $1.21 | |
| Revenue / Share | $2.37 | $2.44 | · | $0.39 | $0.51 | $0.48 | · | $0.70 | $0.78 | $0.61 | · | $0.07 | $0.02 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-2.28 | · | · | · | $-0.52 | · | · | · | $-0.89 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $3.34 | $4.11 | · | $0.12 | $0.33 | $0.54 | · | $1.21 | $1.75 | $2.41 | · | $0.54 | $0.98 | $1.04 | · | $1.18 | |
| EPS (TTM) | $-26.94 | $-29.83 | · | $-51.12 | $-51.27 | $-44.76 | · | $-30.77 | $-31.30 | $-31.35 | · | $-3.91 | $-3.12 | $-2.64 | · | $-0.29 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $21M | · | $24M | $24M | $25M | · | $25M | $23M | $18M | · | $9M | $6M | $6M | · | $5M | |
| Net Income TTM | $-31M | $-26M | · | $-30M | $-30M | $-28M | · | $-19M | $-24M | $-24M | · | $-22M | $-20M | $-20M | · | $-18M | |
| Market Cap | $22M | $18M | · | $12M | $10M | $18M | · | $29M | $35M | $45M | · | $319M | $249M | $300M | · | $390M | |
| P/E | -0.3 | -0.2 | · | -0.2 | -0.2 | -0.5 | · | -1.3 | -1.5 | -2.0 | · | -16.3 | -16.2 | -22.9 | · | -257.2 | |
| P/S | 1.0 | 0.9 | · | 5.9 | 5.0 | 8.5 | · | 13.8 | 17.8 | 30.1 | · | 418.8 | 531.1 | 613.4 | · | 1022.8 | |
| P/B | 1.8 | 2.9 | · | 0.9 | 0.7 | 1.0 | · | 0.8 | 0.9 | 1.1 | · | 6.2 | 4.2 | 4.7 | · | 5.2 | |
| P / Tangible Book | 2.9 | 12.0 | · | 1.5 | 1.0 | 1.7 | · | 1.8 | 1.9 | 2.1 | · | 10.3 | 4.2 | 4.7 | · | 5.2 | |
| P / Cash Flow | · | -5.0 | · | · | · | -3.3 | · | · | · | -5.9 | · | · | · | -57.3 | · | · | |
| Earnings Yield | -351.7% | -449.9% | · | -598.3% | -662.4% | -219.4% | · | -78.7% | -65.0% | -50.0% | · | -6.1% | -6.2% | -4.4% | · | -0.39% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $22M | $26M | $14M | $6M | $6M |
| Margem Bruta % | 38.2% | 32.0% | · | · | · |
| Margem Operacional % | -89.3% | -114.4% | · | · | · |
| Lucro líquido | $-20M | $-29M | $-22M | $-20M | $-13M |
| EPS Diluído | $-17.16 | $-39.96 | $-31.13 | $-2.20 | $-0.27 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.3 | 2.1 | · | · | · |
| Índice de Liquidez Seca | 0.7 | 1.2 | · | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-17M | $-22M | · | · | · |
Investidores institucionais (13F) 10 declarantes · $250K total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
10
Valor detido
$250K
Novas posições
2
Posições encerradas
1
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 2 | 1 | 2 | 1 | · |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado. Variação vs trimestre anterior não mostrada: a cobertura de registrantes difere demais entre esses dois trimestres para uma comparação confiável.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $141.802 | 18.064 | 56,81% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $86.765 | 11.327 | 34,76% | Ações |
| UBS Group AG | $16.484 | 2.152 | 6,60% | Ações |
| MORGAN STANLEY | $2.099 | 274 | 0,84% | Ações |
| SBI Securities Co., Ltd. | $1.501 | 196 | 0,60% | Ações |
| OSAIC HOLDINGS, INC. | $836 | 107 | 0,33% | Ações |
| NATIONAL BANK OF CANADA /FI/ | $85 | 11 | 0,03% | Ações |
| Caitong International Asset Management Co., Ltd | $31 | 4 | 0,01% | Ações |
| ROYAL BANK OF CANADA | $0 | 50 | 0,00% | Ações |
| Motiv8 Investments LLC | $0 | 41 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 3 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 14 de Maio de 2026 | 49,90% | Declaração inicial | Investimento passivo | SEC |
| Lind Global Fund II LP, Lind Global Partners II LLC, Lind Global Macro Fund, LP, Lind Global Partners LLC, Jeff Easton ×3 declarações | 28 de Setembro de 2023 | · | Declaração inicial | · | SEC |
| Timwell Corporation Limited (“Timwell”), Xu Han | 29 de Maio de 2018 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 37 insiders · 11 diretores · 26 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| William Mark Grant | President & CEO | 25 de Março de 2026 A | · | 0 | 0 | $0 |
| Lawrence J Jasinski | Chief Executive Officer | 21 de Maio de 2025 S | 98.728 | 0 | 0 | $0 |
| Almog Adar | Chief Financial Officer | 25 de Março de 2026 A | 262.500 | 0 | 0 | $0 |
| Michael A. Lawless | Chief Financial Officer | 23 de Maio de 2024 P | 4.150 | 0 | 0 | $0 |
| Kevin Hershberger | Chief Financial Officer | 4 de Outubro de 2017 D | 95.676 | 0 | 0 | $0 |
| Keith Dale Rose | Chief Medical Officer | 1 de Maio de 2026 A | 17.083 | 0 | 0 | $0 |
| Jeannine Lynch | VP of Market Access & Strategy | 11 de Dezembro de 2025 A | 96.067 | 0 | 0 | $0 |
| Charles Remsberg | Chief Sales Officer | 11 de Agosto de 2023 A | 200.000 | 0 | 0 | $0 |
| Ofir Koren | Snr VP, R&D and Regulatory | 2 de Julho de 2020 A | 64.995 | 0 | 0 | $0 |
| Jodi Gricci | VP Global Marketing & Training | 10 de Outubro de 2017 S | 32.590 | 0 | 0 | $0 |
| John Vincent Hamilton | VP, Regulatory and Clinical | 25 de Julho de 2016 S | 5.665 | 0 | 0 | $0 |
| Avraham Gabay | Conselheiro | 20 de Agosto de 2026 A | 13.643 | 0 | 0 | $0 |
| Haggai Zamir | Conselheiro | 14 de Agosto de 2026 A | 6.711 | 0 | 0 | $0 |
| Yonason Greenwald | Conselheiro | 14 de Agosto de 2026 A | 6.711 | 0 | 0 | $0 |
| William Mark Sigsbee | Conselheiro | 25 de Março de 2026 A | 11.485 | 0 | 0 | $0 |
| Moshe H Rozenbaum | Conselheiro | 25 de Março de 2026 A | 11.485 | 0 | 0 | $0 |
| Yehuda Reznick | Conselheiro | 25 de Março de 2026 A | 7.657 | 0 | 0 | $0 |
| Miriam Kidron | Conselheiro | 25 de Março de 2026 A | 7.657 | 0 | 0 | $0 |
| Nadav Kidron | Conselheiro | 25 de Março de 2026 A | 7.657 | 0 | 0 | $0 |
| Michael Swinford | Conselheiro | 1 de Agosto de 2025 A | 45.960 | 0 | 0 | $0 |
| Hadar Levy | Conselheiro | 1 de Agosto de 2025 A | 51.576 | 0 | 0 | $0 |
| Randel Richner | Conselheiro | 1 de Agosto de 2025 A | 57.487 | 0 | 0 | $0 |
| Robert J. Marshall Jr. | Conselheiro | 1 de Agosto de 2025 A | 35.920 | 0 | 0 | $0 |
| Joseph E Turk Jr | Conselheiro | 1 de Agosto de 2025 A | 86.457 | 0 | 0 | $0 |
| John William Poduska SR | Conselheiro | 1 de Agosto de 2025 A | 55.953 | 0 | 0 | $0 |
| Jeff Dykan | Conselheiro | 13 de Setembro de 2023 A | 119.157 | 0 | 0 | $0 |
| Aryeh Dan | Conselheiro | 15 de Agosto de 2023 S | 71.062 | 0 | 0 | $0 |
| Yohanan Engelhardt | Conselheiro | 2 de Agosto de 2022 A | 80.585 | 0 | 0 | $0 |
| Yasushi Ichiki | Conselheiro | 2 de Agosto de 2022 A | 80.645 | 0 | 0 | $0 |
| Wayne Weisman | Conselheiro | 2 de Agosto de 2022 A | 50.000 | 0 | 0 | $0 |
| Chunlin Han | Conselheiro | 15 de Maio de 2019 A | 11.029 | 0 | 0 | $0 |
| Ning Cong | Conselheiro | 27 de Março de 2019 A | 144.403 | 0 | 0 | $0 |
| Peter Wehrly | Conselheiro | 27 de Março de 2019 A | 139.223 | 0 | 0 | $0 |
| Deborah Disanzo | Conselheiro | 30 de Abril de 2018 A | 22.727 | 0 | 0 | $0 |
| Glenn P Muir | Conselheiro | 27 de Junho de 2017 A | · | 0 | 0 | $0 |
| Lind Global Fund II LP | Detentor de 10% | 7 de Janeiro de 2025 S | 857.996 | 0 | 0 | $0 |
| Ori Gon | · | 30 de Junho de 2021 A | 241.282 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 2 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
LFWD Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 8 analistas
COMPRA
Alvo mediano
$20.00
+241,9%
2 25,0%
Compra forte
5 62,5%
Compra
1 12,5%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
2 analistas · 2026-09-20Alvo médio $20.00 +241,9%
← Abaixo de todos os alvos
Preço atual $5.85
Mín$10.00
Média$20.00
Máx$30.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| LFWD | $879.6K | -0.0 | -14.1% | -90.4% | -169.3% | 38.2% |
| ICCM | $45M | 2.5 | · | -445.6% | -188.8% | 36.3% |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 14, 2026